$KVYO RISK_REVERSAL 280121 PUT 15.0/CALL 17.5$
Klaviyo just did something most SaaS names couldn't this quarter. $KVYO is at $23.64, +6.8% — and it's not a random pop.
Q3 delivered the combo that actually matters:
•Adjusted EPS $0.22 vs $0.17 expected — ~29% beat, +22% YoY
•Revenue $387.2M vs $379.9M expected — beat
•Full-year guidance raised to $1.537–1.541B
Q4 guide $421–425M , roughly in line
Beat the quarter, raise the year. In a tape that's been punishing any hint of deceleration, that's a signal.
The interesting part is the price action. It didn't gap and fade — it's grinding higher into skepticism:
•2026-11-02: +8.2% to $21.80 on ~11.3M shares (2x normal volume)
•2026-11-10: shakeout to $20.43, intraday low $19.00
•2026-11-13: +3.7% to $22.13 after a 5% pre-market drop got fully reversed
•2026-11-16/17: pushing to $23.64, clearing the $22.1 prior close
Meanwhile the sell side was cutting targets into the print — Mizuho to $24 from $28, Morgan Stanley to $29 from $31, Barclays to $23 from $22. The stock is climbing while analysts trim. That's the market disagreeing with the desk.
Why it matters: Klaviyo's revenue rides on retail marketing spend. Guiding Q4 up into the holiday season is a read-through on merchant budgets — not just a software story.
Honest caveats:
•TTM P/E is in the hundreds on $0.03 EPS — priced on adjusted profitability and growth, not GAAP.
•Recent leg up is on 2.41M shares vs a 5.2M average — thin, easier to give back.
•A director sold 13,989 shares at $20 on 2026-11-06, plus several Form 144 filings. Routine, but it's supply.
What I'm watching: does volume expand above 5M on up days? That's institutions, not short covering. Lose ~$22 and the breakout failed.
Not a recommendation — just the setup. Curious what others think about that Q4 guide.
Comments